Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -7.92x is 90% above its 2-year average of -76.61x, near the high end of its 2-year range (-639.69x–27.17x).
As of the fiscal period ended Thursday, June 30, 2022. 95.32% above its 12-month average of -169.17x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2022 (2022-06-30): -7.92x.
INTEREST COVERAGE RATIO
-7.92x
INTEREST COVERAGE RATIO AVG TTM
-169.17x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+95.32%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-24.21%
vs the sector median at left
Privia Health Group, Inc.
Market Cap
$2.58B
Interest Coverage Ratio
-7.92x
TTM Avg
-169.17x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.61B
Interest Coverage Ratio
-8.77x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.52B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.63B
Interest Coverage Ratio
-0.37x
TTM Avg
0.59x
3Y Avg
204.00x
5Y Avg
353.37x
Market Cap
$2.65B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.66B
Interest Coverage Ratio
1.89x
TTM Avg
1.89x
3Y Avg
0.94x
5Y Avg
0.94x
Market Cap
$2.68B
Interest Coverage Ratio
2.79x
TTM Avg
3.64x
3Y Avg
5.04x
5Y Avg
5.11x
Market Cap
$2.45B
Interest Coverage Ratio
N/A
TTM Avg
5.09x
3Y Avg
6.01x
5Y Avg
15.92x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | $2.58B | -7.92x | -169.17x | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.61B | -8.77x | N/A | N/A | N/A |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.52B | N/A | N/A | N/A | N/A |
| Neogen Corporation (NEOG)vs › | $2.63B | -0.37x | 0.59x | 204.00x | 353.37x |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.65B | N/A | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 1.89x | 1.89x | 0.94x | 0.94x |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 2.79x | 3.64x | 5.04x | 5.11x |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.45B | N/A | 5.09x | 6.01x | 15.92x |
| Precigen, Inc. (PGEN)vs › | $2.73B | -27.57x | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.41B | N/A | N/A | N/A | N/A |
Interest Coverage
-7.9x
Debt/Equity
0.01
Current Ratio
1.62
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-06-30 | -7.92x |
| 2022-03-31 | -49.77x |
| 2021-12-31 | -104.58x |
| 2021-09-30 | -43.87x |
| 2021-06-30 | -639.69x |
| 2021-03-31 | 27.17x |
| 2020-12-31 | 9.52x |
| 2020-09-30 | 16.95x |
| 2020-06-30 | 12.14x |
| 2020-03-31 | 13.91x |
